# ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION

> **NCT04724447** · PHASE1,PHASE2 · COMPLETED · sponsor: **Laureate Institute for Brain Research, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Valganciclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04724447
- **Lead sponsor:** Laureate Institute for Brain Research, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-23
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04724447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04724447, "ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04724447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*